Balamoola rasayana for sciatica
Phase 3
- Conditions
- Health Condition 1: M543- Sciatica
- Registration Number
- CTRI/2024/03/064609
- Lead Sponsor
- Dr Anchumol Joseph
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients fulfilling the diagnostic criteria.
2.Patients with or without radiological evidence-MRI,CT of disc prolapse.
3.Patients with or without radiological evidence-MRI,CT of lumbar spondylosis.
4.Patients between the age groups of 18-70 years and of either sex.
Exclusion Criteria
1.Patients with radiological evidence of fracture of vertebrae, congenital deformities and neoplasm of spine.
2.Pregnancy and lactating mother.
3.Evidence of osteoporosis with BMD less than -2.5
4.Had participated in any clinical trial within 3 months of screening.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes in the signs and symptoms of gridrasi. <br/ ><br>changes in VAS scale <br/ ><br>improvement on the basis of SLR test,bregards test, lasegues sign,bowstring test,femoral nerve stretch test,flip test <br/ ><br>improvement in objective parameters like pain-greenough and fraser scoring method,neurological deficit assessment,assessment of functional ability-sugarbaker and barofsky clinical mobility scale,functional disability assessment-oswestry disability assessment questionnaireTimepoint: group A- 48 days <br/ ><br>group B-61 days
- Secondary Outcome Measures
Name Time Method objective parametersTimepoint: 2 weeks